These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21085709)

  • 21. Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl.
    Maman D; Pujades-Rodriguez M; Nicholas S; McGuire M; Szumilin E; Ecochard R; Etard JF
    AIDS; 2012 Jul; 26(11):1393-8. PubMed ID: 22441247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
    Greig J; Casas EC; O'Brien DP; Mills EJ; Ford N
    AIDS; 2012 Jul; 26 Suppl 1():S31-7. PubMed ID: 22781173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
    Gupta RK; Gregson J; Parkin N; Haile-Selassie H; Tanuri A; Andrade Forero L; Kaleebu P; Watera C; Aghokeng A; Mutenda N; Dzangare J; Hone S; Hang ZZ; Garcia J; Garcia Z; Marchorro P; Beteta E; Giron A; Hamers R; Inzaule S; Frenkel LM; Chung MH; de Oliveira T; Pillay D; Naidoo K; Kharsany A; Kugathasan R; Cutino T; Hunt G; Avila Rios S; Doherty M; Jordan MR; Bertagnolio S
    Lancet Infect Dis; 2018 Mar; 18(3):346-355. PubMed ID: 29198909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.
    Billong SC; Fokam J; Penda CI; Amadou S; Kob DS; Billong EJ; Colizzi V; Ndjolo A; Bisseck AZ; Elat JN
    BMC Infect Dis; 2016 Nov; 16(1):678. PubMed ID: 27846809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].
    Guo Y; Zhou N; Zhao FN; Liu ZQ; Li L; Yu MH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):936-940. PubMed ID: 31484257
    [No Abstract]   [Full Text] [Related]  

  • 28. Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes?
    Zachariah R; Tayler-Smith K; Manzi M; Massaquoi M; Mwagomba B; van Griensven J; van Engelgem I; Arnould L; Schouten EJ; Chimbwandira FM; Harries AD
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):421-30. PubMed ID: 21724219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of quality of life among Cambodian adults living with HIV/AIDS and using antiretroviral therapy: a short report.
    Yang Y; Thai S; Choi J
    AIDS Care; 2016 Dec; 28(12):1546-1550. PubMed ID: 27285879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of estimates of retention in care among a cohort of HIV-positive patients in Uganda in the period before starting ART: a sampling-based approach.
    Nyakato P; Kiragga AN; Kambugu A; Bradley J; Baisley K
    BMJ Open; 2018 Apr; 8(4):e017487. PubMed ID: 29678963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi.
    Chen SC; Yu JK; Harries AD; Bong CN; Kolola-Dzimadzi R; Tok TS; King CC; Wang JD
    Trop Med Int Health; 2008 Apr; 13(4):513-9. PubMed ID: 18282238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for mortality in a south Indian population on generic antiretroviral therapy.
    Rupali P; Mannam S; Bella A; John L; Rajkumar S; Clarence P; Pulimood SA; Samuel P; Karthik R; Abraham OC; Mathai D
    J Assoc Physicians India; 2012 Dec; 60():11-4. PubMed ID: 23781664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.
    Geng EH; Bangsberg DR; Musinguzi N; Emenyonu N; Bwana MB; Yiannoutsos CT; Glidden DV; Deeks SG; Martin JN
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):405-11. PubMed ID: 19745753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya.
    Yiannoutsos CT; An MW; Frangakis CE; Musick BS; Braitstein P; Wools-Kaloustian K; Ochieng D; Martin JN; Bacon MC; Ochieng V; Kimaiyo S
    PLoS One; 2008; 3(12):e3843. PubMed ID: 19048109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique.
    Decroo T; Telfer B; Biot M; Maïkéré J; Dezembro S; Cumba LI; das Dores C; Chu K; Ford N
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):e39-44. PubMed ID: 21084990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.
    Spire B; Carrieri P; Sopha P; Protopopescu C; Prak N; Quillet C; Ngeth C; Ferradini L; Delfraissy JF; Laureillard D
    Antivir Ther; 2008; 13(5):697-703. PubMed ID: 18771053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.
    Rich ML; Miller AC; Niyigena P; Franke MF; Niyonzima JB; Socci A; Drobac PC; Hakizamungu M; Mayfield A; Ruhayisha R; Epino H; Stulac S; Cancedda C; Karamaga A; Niyonzima S; Yarbrough C; Fleming J; Amoroso C; Mukherjee J; Murray M; Farmer P; Binagwaho A
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):e35-42. PubMed ID: 22156912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.